• News

Dupilumab for atopic dermatitis linked to lower antibody levels after COVID-19 infection

  • Healio: Allergy/Asthma
  • New York, NY
  • (April 08, 2022)

Benjamin Ungar, MD, and Emma Guttman-Yassky, MD, PhD, discuss their study on how dupilumab for atopic dermatitis is linked to lower antibody levels after COVID-19 infection.

Learn more